Sanofi boosting stake in Regeneron


  • Business Premium
  • Tuesday, 12 Feb 2013

French drugmaker Sanofi SA is buying more shares in U.S. biotech company Regeneron Pharmaceuticals Inc, its partner in the development of potential blockbuster treatments for cholesterol and rheumatoid arthritis.

Sanofi's plans, disclosed by the companies in separate statements on Monday, boosted both companies' shares.

Article type: metered
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

   

Next In Business News

Elon Musk drops out of US$200bil club again as Tesla tumbles Premium
Latex goods account for 83.1% of total exports for rubber products in Q1 2022 Premium
Ringgit opens marginally higher as greenback demand eases Premium
Singapore economy expands 3.7% in Q1 2022 Premium
Leong Hup faces near-term headwinds Premium
Bursa bounces after sharp losses Premium
Trading ideas: KLK, KLCCP Staple Group, TSH Resources, UWW Holdings, Farm Fresh, Boustead Heavy Industries, Menang, Perak, Sime Darby, Malakoff, Pekat Group and GDeX Premium
Facing crisis, Sri Lanka to cut spending 'to the bone' Premium
India could cut import tax on some edible oils to tame local prices Premium
Africa objects, Malaysia has reservations, on US push to reform health rules at WHO Premium

Others Also Read